Atopic dermatitis is a chronic skin condition that is not contagious and cannot be passed from one person to another. It is often referred to as “eczema” – a broad term for several types of inflammations of the skin.


The word “dermatitis” means inflammation of the skin. “Atopic” refers to a group of diseases often traced to an inherited tendency toward allergic conditions. Often, Atopic dermatitis is referred to as eczema, a broad term used to describe several types of skin inflammation. Of them,  Atopic dermatitis is the most common form of eczema sharing  very similar symptoms.

In atopic dermatitis, the skin becomes extremely itchy. Scratching leads to redness, swelling, cracking, “weeping” clear fluid, and finally, crusting and scaling. Most often, there are periods of time when the disease flares (or worsens), followed by periods of improvement or clearance.


Atopic dermatitis occurs equally in males and females, affecting up to 30% of the United States population. Although atopic dermatitis may occur at any age, onset most often begins in infancy or childhood. Onset after age 30 is less common.

Signs and symptoms on the skin are typically the basis for diagnosis.


  • Atopic pleat (Dennie-Morgan fold): An extra fold of skin that develops under the eye.
  • Cheilitis: Inflammation of the skin on and around the lips.
  • Hyperlinear palms: Increased number of skin creases on the palms.
  • Hyperpigmented eyelids: Eyelids that have become darker in color from inflammation or hay fever
  • Ichthyosis: Dry, rectangular scales on the skin.
  • Keratosis pilaris: Small, rough bumps, generally on the face, upper arms, and thighs
  • Lichenification: Thick, leathery skin resulting from constant scratching and rubbing.
  • Papules: Small, raised bumps that may open when scratched and become crusty and infected
  • Urticaria: Hives (red, raised bumps) that may occur after exposure to an allergen, at the beginning of flares, or after exercise or a hot bath.


Though the causes of atopic dermatitis are not precisely known, the disease seems to result from a combination of inherited tendencies and environmental factors.

Many factors or conditions can make symptoms of atopic dermatitis worse, further triggering the already overactive immune system, aggravating the itch-scratch cycle, and increasing damage to the skin. These factors typically fall into two main categories: irritants and allergens. Emotional factors and some infections and illnesses can also influence atopic dermatitis.

Although the symptoms can be difficult and uncomfortable, the disease can be successfully managed for patients to LIVE FREE and CLEAR.


XTRAC targeted UVB therapy is a cutting-edge treatment for atopic dermatitis. Its well-earned
reputation for extraordinary effectiveness and safety has been proven by physicians around the world who have successfully treated patients without fear of steroid and systemic side effects.

XTRAC has none of the drawbacks often associated with other atopic dermatitis therapies. Some patients, however, experience a reaction similar to sunburn or mild blistering at the site of the treated area and in rare cases, an increase in pigmentation may occur.


Narrowband UVB treatment for Atopic Dermatitis was shown to:

  • Be more effective in patients with moderate to severe atopic dermatitis than other treatment modalities.1
  • Reduce itching (pruritus) by 81% in four weeks. No side effects were reported and no worsening of the atopic dermatitis occurring at 1-month follow-up.2
  • Produce greater improvement when compared with a topical corticosteroid ointment at 6-month follow-up using global assessment scores.3
  • Require a lower cumulative dose for the clearance of atopic dermatitis to achieve comparable clinical results with other photo-therapies.4
  • Be a safe and effective treatment for chronic cases of moderate to severe atopic dermatitis with 80% of children showing good to excellent results.5,6,7
1, 4 Reynolds NJ, Franklin V, Gray JC, Diffey BL, Farr PM. Narrow-Band Ultraviolet B And Broad-Band Ultraviolet A Phototherapy In Adult Atopic Eczema: A Randomized Controlled Trial. Lancet. 2001;357:2012–2016.
2 Baltas E, Csoma Z, Bodai L, Ignacz F, Dobozy A, Kemeny L. Treatment of atopic dermatitis with the xenon chloride excimer laser. J Eur Acad Dermatol Venereal2006; 20(6):657-660.
3 Brenninkmeijer EEA, Spuls PI, Lindeboom R, van der Wal AC, Bos JD, Wolkerstorfer A. Excimer laser vs. clobetasol propionate 0.05% ointment in prurigo form of atopic dermatitis: a randomized controlled trial, a pilot. Br ] Dermatol. 2010;163(4):823-831.
5 Annalisa Patrizi, Beatrice Raone, Giulia Maria Ravaioli. Management of atopic dermatitis: safety and efficacy of phototherapy. Clinical, Cosmetic and Investigational Dermatology 2015:8 511–520.
6 E. Tan, D. Lim, and M. Rademaker, Narrowband UVB Phototherapy In Children: A New Zealand Experience. Australasian Journal of Dermatology, vol. 51, no. 4, pp. 268–273, 2010.
7 M. Pavlovsky, S. Baum, D. Shpiro, L. Pavlovsky, and F. Pavlotsky, Narrow Band UVB: Is It Effective And Safe For Paediatric Psoriasis And Atopic Dermatitis. Journal of the European Academy of Dermatology and Venereology, vol. 25, no. 6, pp. 727–729, 2011.


Call us at 1-800-974-8958 and we can tell you. If your physician doesn’t offer XTRAC Therapy, we can provide you the name of a physician nearest you that does.